Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor–Induced Hyperglycemia: A Case Report

Context. Many phosphoinositide-3-kinase (PI3K) inhibitors are under trial for cancer treatment. We present a patient taking taselisib who developed ketoacidosis within 1 week of starting canagliflozin. Case Description. A 69-year-old female patient with no previous history of diabetes mellitus was e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowman, Christopher, Abramson, Vandana, Wellons, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571767/
https://www.ncbi.nlm.nih.gov/pubmed/28856166
http://dx.doi.org/10.1177/2324709617725351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571767/
https://www.ncbi.nlm.nih.gov/pubmed/28856166
http://dx.doi.org/10.1177/2324709617725351

Ejemplares similares